甘油三酯葡萄糖乘积指数对急性冠状动脉综合征患者行急诊PCI术远期预后的预测价值
作者:
作者单位:

(1.西安交通大学第一附属医院心血管内科,陕西省西安市 710061;2.渭南市中心医院心血管内科,陕西省渭南市 714000)

作者简介:

张勇,硕士,主治医师,主要从事冠心病临床研究,E-mail:zhangyong19860301@163.com。

基金项目:

陕西省科技厅重点研发计划(2022SF-120)


The predictive value of the triglyceride-glucose index for cardiovascular and cerebrovascular outcomes in patients with acute coronary syndrome underwent emergency percutaneous coronary intervention
Author:
Affiliation:

1.Department of Cardiovascular Medicine, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China;2.Department of Cardiovascular Medicine, Weinan Central Hospital, Weinan, Shaanxi 714000, China)

  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
    摘要:

    目的]研究甘油三酯葡萄糖乘积(TyG)指数对急性冠状动脉综合征(ACS)患者行急诊经皮冠状动脉介入治疗(PCI)远期预后的预测价值。 [方法]共纳入了2 249例行急诊PCI术的ACS患者,根据TyG指数的中位数将患者分为高TyG指数组及低TyG指数组。比较两组主要不良心脑血管事件(MACCE)发生情况。单因素及多因素Cox分析评价TyG对MACCE的预测价值,亚组分析评估TyG指数对MACCE预测价值的一致性。 [结果]在66个月随访期间,共有299(13.3%)例患者发生MACCE。与低TyG指数组比,高TyG指数组的MACCE(17.1%比9.5%,P<0.001)、全因死亡(6.2%比3.7%,P=0.007)、心源性死亡(4.4%比2.1%,P=0.002)、非致死性心肌梗死 (1.0%比0.3%,P=0.001)、非致死性缺血性卒中(2.0%比1.0%,P=0.039)和缺血驱使的血运重建(7.8%比4.8%,P=0.001)的发生率明显升高。多因素Cox分析显示TyG指数是MACCE的独立预测因子(HR 1.710,95%CI 1.304~2.242,P<0.001)。亚组分析显示,TyG指数在不同亚组中对MACCE的独立预测作用仍然存在。 [结论]TyG指数是ACS患者行急诊PCI术远期MACCE的独立预测因子。

    Abstract:

    Aim To investigate the relationship between the triglyceride-glucose (TyG) index and major adverse cardiovascular and cerebrovascular events (MACCE) in the acute coronary syndrome(ACS) patients underwent emergency percutaneous coronary intervention (PCI) with drug-eluting stents. Methods Overall, 2 249 patients with ACS underwent emergency PCI were enrolled in this study. The patients were divided into high TyG index group and low TyG index group according to the median TyG index. The incidence of endpoint events as follows:all-cause death, non-fatal myocardial infarction(MI), non-fatal ischemia stroke, and ischemia-driven revascularization were determined and compared between two groups.Unitivariate and multivariate Cox analysis were used to evaluate the predictive value of the TyG index for MACCE. Subgroup analysis was used to evaluate the consistency of the predictive value of the TyG index for MACCE. Results Overall, 299 (13.3%) endpoint events were documented during a 66-month follow-up. Compared with the low TyG index group, the high TyG index group had a significantly higher incidence of MACCE (17.1% vs. 9.5%, P<0.001), all-cause death (6.2% vs. 3.7%, P=0.007), cardiac death (4.4% vs. 2.1%, P=0.002), non-fatal MI (1.0% vs. 0.3%, P=0.001), non-fatal ischemia stroke (2.0% vs. 1.0%, P=0.039) and ischemia-driven revascularization (7.8% vs. 4.8%, P=0.001). The multivariable Cox regression analysis further revealed that the TyG index was an independent predictor of MACCE (hazard ratio (HR)1.0,5% confidence interval (CI) 1.304~2.242,P<0.001). The results of subgroup analysis showed that the predictive effect of TyG index on MACCE still existed in different subgroups. Conclusion The TyG index might be an independent predictor of MACCE in patients with ACS underwent emergency PCI with drug-eluting stents.

    参考文献
    [1] EISEN A, GIUGLIANO R P, BRAUNWALD E.Updates on acute coronary syndrome:a review.JAMA Cardiol, 6,1(6):718-730.
    [2] BENJAMIN E J, VIRANI S S, CALLAWAY C W, et al.Heart disease and stroke statistics-2018 update:a report from the American heart association.Circulation, 8,7(12):e67-e492.
    [3] JERNBERG T, HASVOLD P, HENRIKSSON M, et al.Cardiovascular risk in post-myocardial infarction patients:nationwide real world data demonstrate the importance of a long-term perspective.Eur Heart J, 5,6(19):1163-1170.
    [4] FOX K A A, CARRUTHERS K F, DUNBAR D R, et al.Underestimated and under-recognized:the late consequences of acute coronary syndrome (GRACE UK-Belgian Study).Eur Heart J, 0,1(22):2755-2764.
    [5] ORMAZABAL V, NAIR S, ELFEKY O, et al.Association between insulin resistance and the development of cardiovascular disease.Cardiovasc Diabetol, 8,7(1):122.
    [6] DI P A, DEFRONZO R A.Insulin resistance and atherosclerosis:implications for insulin-sensitizing agents.Endocr Rev, 9,0(6):1447-1467.
    [7] MUNIYAPPA R, LEE S, CHEN H, et al.Current approaches for assessing insulin sensitivity and resistance in vivo:advantages, limitations, and appropriate usage.Am J Physiol Endocrinol Metab, 8,4(1):E15-E26.
    [8] DU T T, YUAN G, ZHANG M X, et al.Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance.Cardiovasc Diabetol, 4,3:146.
    [9] NAVARRO-GONZLEZ D, SNCHEZ-IGO L, PASTRANA-DELGADO J, et al.Triglyceride-glucose index(TyG index)in comparison with fasting plasma glucose improved diabetes prediction in patients with normal fasting glucose:the vascular-metabolic CUN cohort.Prev Med, 6,6:99-105.
    [10] WANG A X, WANG G Y, LIU Q, et al.Triglyceride-glucose index and the risk of stroke and its subtypes in the general population:an 11-year follow-up.Cardiovasc Diabetol, 1,0(1):46.
    [11] TIAN X, ZUO Y T, CHEN S H, et al.Triglyceride-glucose index is associated with the risk of myocardial infarction:an 11-year prospective study in the Kailuan cohort.Cardiovasc Diabetol, 1,0(1):19.
    [12] LUO JW, DUAN WH, YU YQ, et al.Prognostic significance of triglyceride-glucose index for adverse cardiovascular events in patients with coronary artery disease:a systematic review and Meta-analysis .Front Cardiovasc Med, 1,8:774781.
    [13] IBANEZ B, JAMES S, AGEWALL S, et al.2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European society of cardiology (ESC).Eur Heart J, 8,9(2):119-177.
    [14] ROFFI M, PATRONO C, COLLET J P, et al.2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation:task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European society of cardiology (ESC).Eur Heart J, 6,7(3):267-315.
    [15] American Diabetes Association.Diagnosis and classification of diabetes mellitus.Diabetes Care, 0,3 Suppl 1(Suppl 1):S62-S69.
    [16] GUERRERO-ROMERO F, SIMENTAL-MENDA L E, GONZLEZ-ORTIZ M, et al.The product of triglycerides and glucose, a simple measure of insulin sensitivity.Comparison with the euglycemic-hyperinsulinemic clamp.J Clin Endocrinol Metab, 0,5(7):3347-3351.
    [17] LEVEY A S, CORESH J, GREENE T, et al.Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.Ann Intern Med, 6,5(4):247-254.
    [18] ALFONSO F, BYRNE R A, RIVERO F, et al.Current treatment of in-stent restenosis.J Am Coll Cardiol, 4,3(24):2659-2673.
    [19] BAIGENT C, BLACKWELL L, EMBERSON J, et al.Efficacy and safety of more intensive lowering of LDL cholesterol:a Meta-analysis of data from 170 000 participants in 26 randomised trials.Lancet, 0,6(9753):1670-1681.
    [20] CANNON C P, BLAZING M A, GIUGLIANO R P, et al.Ezetimibe added to statin therapy after acute coronary syndromes.N Engl J Med, 5,2(25):2387-2397.
    [21] SABATINE M S, GIUGLIANO R P, KEECH A C, et al.Evolocumab and clinical outcomes in patients with cardiovascular disease.N Engl J Med, 7,6(18):1713-1722.
    [22] RIDKER P M, EVERETT B M, THUREN T, et al.Antiinflammatory therapy with canakinumab for atherosclerotic disease.N Engl J Med, 7,7(12):1119-1131.
    [23] 董亚兰, 胡德胜.动脉粥样硬化的炎症应答特征及运用.中国动脉硬化杂志, 2,0(4):304-312.DONG Y L, HU D S.Characteristics and application of inflammatory response in atherosclerosis.Chin J Arterioscler, 2,0(4):304-312.
    [24] MECHANICK J I, FARKOUH M E, NEWMAN J D, et al.Cardiometabolic-based chronic disease,adiposity and dysglycemia drivers:JACC state-of-the-art review.J Am Coll Cardiol, 0,5(5):525-538.
    [25] GAST K B, TJEERDEMA N, STIJNEN T, et al.Insulin resistance and risk of incident cardiovascular events in adults without diabetes:Meta-analysis.PLoS One, 2,7(12):e52036.
    [26] REWERS M, ZACCARO D, D'AGOSTINO R, et al.Insulin sensitivity, insulinemia, and coronary artery disease:the insulin resistance atherosclerosis study.Diabetes Care, 4,7(3):781-787.
    [27] TENENBAUM A, MOTRO M, FISMAN E Z, et al.Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients.Eur Heart J, 5,6(19):2032-2038.
    [28] WU S J, LIU W, MA Q, et al.Association between insulin resistance and coronary plaque vulnerability in patients with acute coronary syndromes:insights from optical coherence tomography.Angiology, 9,0(6):539-546.
    [29] BONORA E, KIECHL S, WILLEIT J, et al.Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in Caucasian subjects from the general population:the Bruneck study.Diabetes Care, 7,0(2):318-324.
    [30] KEDHI E, KENNEDY M W, MAEHARA A, et al.Impact of TCFA on unanticipated ischemic events in medically treated diabetes mellitus:insights from the PROSPECT study.JACC Cardiovasc Imaging, 7,0(4):451-458.
    [31] SIMENTAL-MENDA L E, RODRGUEZ-MORN M, GUERRERO-ROMERO F.The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects.Metab Syndr Relat Disord, 8,6(4):299-304.
    [32] SNCHEZ-IGO L, NAVARRO-GONZLEZ D, FERNNDEZ-MONTERO A, et al.The TyG index may predict the development of cardiovascular events.Eur J Clin Invest, 6,6(2):189-197.
    [33] LAMBRINOUDAKI I, KAZANI M V, ARMENI E, et al.The TyG index as a marker of subclinical atherosclerosis and arterial stiffness in lean and overweight postmenopausal women.Heart Lung Circ, 8,7(6):716-724.
    [34] SHI W R, XING L Y, JING L, et al.Value of triglyceride-glucose index for the estimation of ischemic stroke risk:insights from a general population.Nutr Metab Cardiovasc Dis, 0,0(2):245-253.
    [35] THOMAS B.The global burden of diabetic kidney disease:time trends and gender Gaps.Curr Diab Rep, 9,9(4):18.
    [36] SUNG K C, PARK H Y, KIM M J, et al.Metabolic markers associated with insulin resistance predict type 2 diabetes in Koreans with normal blood pressure or prehypertension.Cardiovasc Diabetol, 6,5(1):47.
    [37] LAXY M, HUNGER M, STARK R, et al.The burden of diabetes mellitus in patients with coronary heart disease:a methodological approach to assess quality-adjusted life-years based on individual-level longitudinal survey data.Value Health, 5,8(8):969-976.
    [38] 杨珺.口服药物联合甘精胰岛素治疗2型糖尿病的临床疗效分析.中国实用医药, 2,7(27):165-167.YANG J.Analysis of the clinical efficacy of oral drugs combined with insulin glargine in the treatment of type 2 diabetes mellitus.Chin Prac Med, 2,7(27):165-167.
    [39] 孙峥, 王笑烨, 袁景, 等.达格列净联合利拉鲁肽治疗非酒精性脂肪性肝病合并2型糖尿病患者短期疗效研究.实用肝脏病杂志, 2,5(6):796-799.SUN Z, WANG X Y, YUAN J, et al.Short-term efficacy of dapagliflozin and liraglutide combination in treatment of patients with non-alcoholic fatty liver disease and diabetes mellitus type 2.J Prac Hepatol, 2,5(6):796-799.
    [40] 徐爽, 童慧昕, 梁琳琅, 等.二甲双胍、达格列净、利拉鲁肽联合治疗新诊断超重或肥胖2型糖尿病患者临床疗效及安全性.临床军医杂志, 2,0(12):1252-1254.XU S, TONG H X, LIANG L L, et al.Clinical efficacy and safety of combined treatment of metformin, dapagliflozin and liraglutide in newly diagnosed overweight or obese patients with type 2 diabetes mellitus.Clin J Med Offic, 2,0(12):1252-1254.
    相似文献
    引证文献
引用本文

张勇,蔡翔,钟钟,宁菲菲,郭宁.甘油三酯葡萄糖乘积指数对急性冠状动脉综合征患者行急诊PCI术远期预后的预测价值[J].中国动脉硬化杂志,2023,31(8):687~696.

复制
分享
文章指标
  • 点击次数:493
  • 下载次数: 1031
历史
  • 收稿日期:2022-12-03
  • 最后修改日期:2023-03-10
  • 在线发布日期: 2023-07-20